Sonnet Biotherapeutics Holdings Stock Overlap Studies Triple Exponential Moving Average

SONN Stock  USD 2.98  0.09  3.11%   
Sonnet Biotherapeutics overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against Sonnet Biotherapeutics. Sonnet Biotherapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. Sonnet Biotherapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. Sonnet Biotherapeutics Triple Exponential Moving Average indicator shows smoothing effect of Sonnet Biotherapeutics price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Sonnet Biotherapeutics Technical Analysis Modules

Most technical analysis of Sonnet Biotherapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sonnet from various momentum indicators to cycle indicators. When you analyze Sonnet charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sonnet Biotherapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sonnet Biotherapeutics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sonnet Biotherapeutics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Sonnet Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sonnet Biotherapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Sonnet Biotherapeutics's intrinsic value. In addition to deriving basic predictive indicators for Sonnet Biotherapeutics, we also check how macroeconomic factors affect Sonnet Biotherapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2024 (projected)
Interest Debt Per Share0.00378829.4K
Revenue Per Share1.7791.8K
Hype
Prediction
LowEstimatedHigh
0.142.899.74
Details
Intrinsic
Valuation
LowRealHigh
0.142.779.62
Details
Naive
Forecast
LowNextHigh
0.063.1910.04
Details
1 Analysts
Consensus
LowTargetHigh
66.4373.0081.03
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 40 shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonnet Biotherapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.96)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.97)
Return On Equity
(2.65)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.